Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea; Department of Internal Medicine, Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center, Seoul, Korea.
Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea.
Gastroenterology. 2022 Sep;163(3):637-648.e2. doi: 10.1053/j.gastro.2022.05.032. Epub 2022 May 25.
BACKGROUND & AIMS: The increasing prevalence of obesity at younger ages is concurrent with an increased earlier-onset colorectal cancer (CRC) (before age 50 years) incidence, particularly left-sided colon cancer. We investigated whether obesity and metabolic syndrome (MetS) are associated with increased earlier-onset CRC risk according to tumor location. METHODS: Our nationwide population-based cohort study enrolled 9,774,081 individuals who underwent health checkups under the Korean National Health Insurance Service from 2009 to 2010, with follow-up until 2019. We collected data on age, sex, lifestyle factors, body mass index (BMI), waist circumference (WC), blood pressure, and laboratory findings. A multivariate Cox proportional hazards regression analysis was performed. RESULTS: A total of 8320 earlier-onset and 57,257 later-onset CRC cases developed during follow-up. MetS was associated with increased earlier-onset CRC (adjusted hazard ratio, 1.20; 95% CI, 1.14-1.27), similar to later-onset CRC (adjusted hazard ratio, 1.19; 95% CI, 1.17-1.21). The adjusted hazard ratios for earlier-onset CRC with 1, 2, 3, 4, and 5 MetS components were 1.07 (95% CI, 1.01-1.13), 1.13 (95% CI, 1.06-1.21), 1.25 (95% CI, 1.16-1.35), 1.27 (95% CI, 1.15-1.41), and 1.50 (95% CI, 1.26-1.79), respectively (P for trend < .0001). We found that higher body mass index and larger waist circumference were significantly associated with increased earlier-onset CRC (P for trend < .0001). These dose-response associations were significant in distal colon and rectal cancers, although not in proximal colon cancers. CONCLUSIONS: MetS and obesity are positively associated with CRC before age 50 years with a similar magnitude of association as people diagnosed after age 50 years. Thus, people younger than 50 years with MetS require effective preventive interventions to help reduce CRC risk.
背景与目的:肥胖在更年轻时的流行率增加与结直肠癌(CRC)(50 岁之前)发病率的提前发生,尤其是左侧结肠癌的提前发生有关。我们研究了肥胖和代谢综合征(MetS)是否与肿瘤位置相关的更早发生 CRC 风险增加有关。
方法:我们进行了一项全国性基于人群的队列研究,纳入了 2009 年至 2010 年期间在韩国国家健康保险服务下接受健康检查的 9774081 名个体,随访至 2019 年。我们收集了年龄、性别、生活方式因素、体重指数(BMI)、腰围(WC)、血压和实验室检查结果的数据。进行了多变量 Cox 比例风险回归分析。
结果:在随访期间,共发生了 8320 例更早发生和 57257 例更晚发生的 CRC 病例。MetS 与更早发生的 CRC 相关(调整后的危险比,1.20;95%CI,1.14-1.27),与更晚发生的 CRC 相似(调整后的危险比,1.19;95%CI,1.17-1.21)。更早发生 CRC 中具有 1、2、3、4 和 5 个 MetS 成分的调整后的危险比分别为 1.07(95%CI,1.01-1.13)、1.13(95%CI,1.06-1.21)、1.25(95%CI,1.16-1.35)、1.27(95%CI,1.15-1.41)和 1.50(95%CI,1.26-1.79)(趋势 P<.0001)。我们发现更高的 BMI 和更大的腰围与更早发生的 CRC 显著相关(趋势 P<.0001)。尽管在近端结肠癌中没有发现,但这些剂量反应关联在远端结肠癌和直肠癌中是显著的。
结论:MetS 和肥胖与 50 岁之前的 CRC 呈正相关,其关联程度与 50 岁以后诊断的人群相似。因此,50 岁以下患有 MetS 的人需要有效的预防干预措施来帮助降低 CRC 风险。
Int J Obes (Lond). 2011-9-6
Front Cell Dev Biol. 2025-8-13
Nat Rev Endocrinol. 2025-8-8
Clin Transl Gastroenterol. 2025-5-28